SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is experiencing significant discussion and price action driven by a political statement concerning institutional home buying. Despite an initial market reaction, the community largely views this as a bullish catalyst for Opendoor, asserting that as an iBuyer facilitating individual homeownership, the company benefits from reduced institutional competition and a revitalized consumer housing market. Many are interpreting the stock's volatility as an opportunity to accumulate shares, anticipating a strong upward move.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending strongly due to enthusiasm over plans to scale its blockchain-based Plastic Cycle Token traceability system, which utilizes molecular identity technology to track plastics. The community is actively discussing the potential for a significant short squeeze, with many drawing parallels to its history of explosive rallies and highlighting limited shares available to borrow.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is capturing significant attention following news of its innovative 3D-printed fuel tank preparing for an upcoming SpaceX mission, highlighting its role in space-based infrastructure. The community is actively discussing the company's remarkably low float and high short interest, sparking intense speculation about a potential short squeeze and drawing comparisons to early-stage space giants.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. (CRML) is gaining significant attention as it formally greenlit the construction of an Arctic-grade pilot plant and storage facility for its Tanbreez rare earth project in Greenland. This catalyst is intensified by active community discussion and political rhetoric regarding potential U.S. strategic interest or acquisition of Greenland for critical minerals, which many believe could lead to a substantial short squeeze and propel the stock higher due to its importance in diversifying rare earth supply chains.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is actively discussed following a Scotiabank downgrade to "Underperform," which the community largely views as a manipulative "hit piece" to benefit shorts or competitors. Investors are dismissing valuation concerns, buying dips, and holding strong, anticipating upcoming catalysts like the Bluebird 7 launch and MNO partnerships to continue the stock's significant upward momentum as a leader in global satellite-to-cellular connectivity.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending driven by its CES 2026 announcements regarding new AI PC processors built on its advanced 18A manufacturing process, alongside Mobileye's acquisition of Mentee Robotics. The community is divided, debating if these developments validate Intel's strategic turnaround in US chip production and AI, or if historical volatility and market skepticism will continue to challenge sustained gains.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is experiencing significant bullish momentum, driven by discussions around an increasingly constrained short float, high borrow fees, and calls for a massive short squeeze. The trading community is actively speculating on its potential for a parabolic upward move, drawing comparisons to its history of extreme volatility and other low-float "China pump" stocks.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics (GLUE) is gaining significant attention following positive interim Phase 1 data for its MRT-8102 molecular glue degrader, which demonstrated profound reductions in inflammatory markers for cardiovascular risk. This clinical advancement, alongside the company's substantial partnership with Novartis and notable short interest, is driving community discussions about the innovative platform's broad therapeutic potential and potential for further appreciation. Investors are actively debating the long-term value proposition and the possibility of a short squeeze.

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

PMGC Holdings Inc.

PMGC Holdings (ELAB) is a major topic after undergoing a reverse stock split and announcing strategic developments, including a share acquisition in a modular nuclear energy company and a subsidiary's aerospace certification. The community is intensely focused on the stock's extremely low public float, widely comparing its potential to past "squeeze" plays like SMX, and speculating on significant upward movement from short covering. Sentiment is driven by this low float, alongside discussions of the company's substantial cash per share and its engagement in high-growth sectors, despite reports of some brokers restricting buy orders.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is surging amidst immediate market chatter regarding proposed policy changes to restrict institutional single-family home purchases, alongside widespread community anticipation of a significant refinancing boom in 2026 as interest rates fall. Investors are actively discussing RKT's comprehensive mortgage and real estate ecosystem, enhanced by recent strategic acquisitions and AI investments, as a prime beneficiary of these evolving market conditions and favorable technical setups.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prime Medicine (NYSE:PRME) Trading Down 3.3% - Here's What Happened

Prime Medicine (NYSE:PRME) Trading Down 3.3% - Should You Sell...

Cathie Wood shells out $1.3 million on biotech stock

On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in the gene-editing play. For the most part, it...

Lifesci Capital Predicts Prime Medicine FY2025 Earnings

Prime Medicine, Inc. (NYSE:PRME - Free Report) - Analysts at Lifesci Capital issued their FY2025 EPS estimates for shares of Prime Medicine in a research note issued to investors on Tuesday, December...

Prime Medicine (NASDAQ:PRME) Trading Down 3.8% - Here's What Happened

Prime Medicine (NASDAQ:PRME) Stock Price Down 3.8% - Here's What Happened...

Prime Medicine (NYSE:PRME) Stock Price Down 4.2% - Should You Sell?

Prime Medicine (NYSE:PRME) Stock Price Down 4.2% - Should You Sell...

Prime Medicine (NASDAQ:PRME) Upgraded at Lifesci Capital

Lifesci Capital upgraded shares of Prime Medicine to a "strong-buy" rating in a report on Tuesday...

Lifesci Capital Begins Coverage on Prime Medicine (NYSE:PRME)

Lifesci Capital initiated coverage on Prime Medicine in a research report on Tuesday. They set an "outperform" rating and a $6.00 target price on the stock...

Prime Medicine, Inc. (NYSE:PRME) Given Consensus Rating of "Moderate Buy" by Brokerages

Prime Medicine, Inc. (NYSE:PRME - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six ratings firms that are presently covering the stock, Marketbeat.com reports...

Prime Medicine (NYSE:PRME) Shares Gap Up - Should You Buy?

Prime Medicine (NYSE:PRME) Shares Gap Up - Should You Buy...

Prime Medicine (NASDAQ:PRME) Shares Gap Up - Still a Buy?

Prime Medicine (NASDAQ:PRME) Shares Gap Up - Time to Buy...

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Prime Medicine Inc

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

Current Price	$3.96
Prev Close	$3.70
Open	$3.84
Dividend Yield	0.00%
50-Day Moving Average	$3.90
Beta	2.09
Avg. Volume	3.81M
PE Ratio	-2.51

52-Week High	$6.94
52-Week Low	$1.11
Market Capitalization	$667.89M
EPS (Annual)	-$1.65
Price to Book	4.12
Revenue Per Employee	$13,939.25
Enterprise Value/EBITDA	N/A

PRME
Prime Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PRME News

PRMEPrime Medicine Inc